Pentapeptides as minimal functional units in cell biology and immunology

Current Protein and Peptide Science

Volumn 14, Issue 2, 2013, Pages 111-120

  Kanduc, Darja ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

Active site motifs; Immune recognition; Minimal determinants; Pentapeptide epitopes; Pentapeptide inhibitors; Pentapeptide substrates; Pentapeptides

Indexed keywords

CASPASE 3; CASPASE 9; CHOLESTEROL; CYCLIN DEPENDENT KINASE; CYCLINE; ENTEROSTATIN; EPITOPE; LAMININ B 1 CHAIN; PENTAGASTRIN; PENTAPEPTIDE; THROMBOSPONDIN 1; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; AMINOACYLATION; ANTIGEN RECOGNITION; APOPTOSIS; ARABIDOPSIS; CELL ADHESION; CELL COMMUNICATION; CELL DENSITY; CELL GROWTH; CYTOLOGY; DIABETES MELLITUS; ENZYME INHIBITION; HUMAN; IMMUNE RESPONSE; IMMUNOLOGY; METASTASIS; NEUROTOXICITY; NONHUMAN; PROTEIN DOMAIN; REVIEW; SIGNAL TRANSDUCTION; THROMBOCYTE AGGREGATION; THROMBOSIS;

AMYLOID; ANIMALS; APOPTOSIS; CELL BIOLOGY; CELL MOVEMENT; EPITOPES, T-LYMPHOCYTE; HUMANS; OLIGOPEPTIDES; PEPTIDE FRAGMENTS;

EID: 84878622690     PISSN: 13892037     EISSN: 18755550     Source Type: Journal    
DOI: 10.2174/1389203711314020003     Document Type: Review

References (155)

1. Wang, L.K.; Shuman, S. Mutational analysis defines the 5'-kinase and 3'-phosphatase active sites of T4 polynucleotide kinase. Nucleic Acids Res., 2002, 30, 1073-1080.
2. Li, M.; Ding, Y.; Mu, Y.; Ao, J.; Chen, X. Molecular cloning and characterization of caspase-3 in large yellow croaker (Pseudosciaena crocea). Fish Shellfish Immunol., 2011, 30, 910-916.
3. Reis, M.I.; do Vale, A.; Pinto, C.; Nascimento, D.S.; Costa-Ramos, C.; Silva, D.S.; Silva, M.T.; Dos Santos, N.M. First molecular cloning and characterisation of caspase-9 gene in fish and its involvement in a gram negative septicaemia. Mol. Immunol., 2007, 44, 1754-1764.
4. Thelander, L. The amino acid sequence of a peptide containing the active center disulfide of thioredoxin reductase from Escherichia coli. J. Biol. Chem., 1970, 245, 6026-6029.
5. Kenney, W. C.; Walker, W. H.; Kearney, E. B.; Zeszotek, E.; Singer T. P. Amino acid sequence at the active center of succinate dehydrogenase. Biochem. Biophys. Res. Commun., 1970, 41, 488-491.
6. Nagatsu, T. Progress in monoamine oxidase (MAO) research in relation to genetic engineering. Neurotoxicology, 2004, 25, 11-20.
7. Kim, S. H.; Park, I. H.; Lee, S. C.; Lee, Y. S.; Zhou-Yi; Kim, C. M.; Ahn, S. C.; Choi Y. L. Discovery of three novel lipase (lipA1, lipA2, and lipA3) and lipase-specific chaperone (lipB) genes present in Acinetobacter sp. DYL129. Appl. Microbiol. Biotechnol., 2008, 77, 1041-1051.
8. Tao, W.; Lee M.H.; Wu J.; Kim N.H.; Lee, S. W. Isolation and characterization of a family VII esterase derived from alluvial soil metagenomic library. J. Microbiol., 2011, 49, 178-185.
9. Bayer, S.; Kunert, A.; Ballschmiter, M.; Greiner-Stoeffele, T. Indication for a new lipolytic enzyme family: isolation and characterization of two esterases from a metagenomic library. J. Mol. Microbiol. Biotechnol., 2010, 18, 181-187.
10. Yang, X.; Lin, X.; Fan, T.; Bian, J.; Huang, X. Cloning and expression of lipP, a gene encoding a cold-adapted lipase from Moritella sp.2-5-10-1. Curr. Microbiol., 2008, 56, 194-198.
11. Kang, C.H.; Oh, K.H.; Lee, M.H.; Oh, T.K.; Kim, B.H.; Yoon, J. A novel family VII esterase with industrial potential from compost metagenomic library. Microb. Cell Fact., 2011, 10, 41.
12. Debelyy, M.O.; Thoms, S.; Connerth, M.; Daum, G.; Erdmann, R. Involvement of theSaccharomyces cerevisiae hydrolase Ldh1p in lipid homeostasis. Eukaryot. Cell, 2011, 10, 776-781.
13. Sultana, R.; Tanneeru, K.; Guruprasad L. The PE-PPE domain in mycobacterium reveals a serine/hydrolase fold and function: an in-silico analysis. PLoS One, 2011, 6, e16745.
14. Thoms, S.; Debelyy, M.O.; Connerth, M.; Daum, G.; Erdmann, R. The putative Saccharomyces cerevisiae hydrolase Ldh1p is localized to lipid droplets. Eukaryot. Cell, 2011, 10, 770-775.
15. Li, T.; Froeyen, M.; Herdewijn, P. Comparative structural dynamics of Tyrosyl-tRNA synthetase complexed with different substrates explored by molecular dynamics. Eur. Biophys. J., 2008, 38, 25-35.
16. Li, L.; Yu, L.; Huang, Q. Molecular trigger for pre-transfer editing pathway in Valyl-tRNA synthetase: a molecular dynamics simulation study. J. Mol. Model., 2011, 17, 555-564.
17. Retailleau, P.; Weinreb, V.; Hu, M.; Carter, C.W. Jr. Crystal structure of tryptophanyl-tRNA synthetase complexed with adenosine-5' tetraphosphate: evidence for distributed use of catalytic binding energy in amino acid activation by class I aminoacyl-tRNA synthetases. J. Mol. Biol., 2007, 369, 108-128.
18. Gomis-Rüth, F.X.; Botelho, T.O.; Bode, W. A standard orientation for metallopeptidases. Biochim. Biophys. Acta, 2012, 1824, 157-163.
19. Bothe, M.K.; Mundhenk, L.; Beck, C.L.; Kaup, M.; Gruber, A.D. Impaired autoproteolytic cleavage of mCLCA6, a murine integral membrane protein expressed in enterocytes, leads to cleavage at the plasma membrane instead of the endoplasmic reticulum. Mol. Cells, 2012, 33, 251-257.
20. Chen, G.; Law, K.; Ho, P.; Zhang, X.; Li, N. EGY2, a chloroplast membrane metalloprotease, plays a role in hypocotyl elongation in Arabidopsis. Mol. Biol. Rep., 2012, 39, 2147-2155.
21. Peer, W.A. The role of multifunctional M1 metallopeptidases in cell cycle progression. Ann. Bot., 2011, 107, 1171-1181.
22. Hooper, N.M. Families of zinc metalloproteases. FEBS Lett., 1994, 354, 1-6.
23. Perlman, R.K.; Gehm, B.D.; Kuo, W.L.; Rosner, M.R. Functional analysis of conserved residues in the active site of insulindegrading enzyme. J. Biol. Chem., 1993, 268, 21538-21544.
24. Morrison, A.; Bell, J.B.; Kunkel, T.A.; Sugino, A. Eukaryotic DNA polymerase amino acid sequence required for 3'----5' exonuclease activity. Proc. Natl. Acad. Sci., U.S.A., 1991, 88, 9473-9477.
25. Hall, J.D.; Orth, K.L.; Sander, K.L.; Swihart, B.M.; Senese, R.A. Mutations within conserved motifs in the 3'-5' exonuclease domain of herpes simplex virus DNA polymerase. J. Gen. Virol., 1995, 76, 2999-3008.
26. Teo, I.A.; Griffin, B.E.; Jones, M.D. Characterization of the DNA polymerase gene of human herpesvirus 6. J. Virol., 1991, 65, 4670-4680.
27. Rafferty, J.A.; Tumelty, J.; Skorvaga, M.; Elder, R.H.; Margison, G.P.; Douglas, K.T. Site-directed mutagenesis of glutamic acid 172 to glutamine completely inactivated human O6-alkylguanine-DNA-alkyltransferase. Biochem. Biophys. Res. Commun., 1994, 199, 285-291
28. Hariprasad, G.; Kumar, M.; Srinivasan, A.; Kaur, P.; Singh, T.P.; Jithesh, O. Structural analysis of a group III Glu62-phospholipase A2 from the scorpion, Mesobuthus tamulus: Targeting and reversible inhibition by native peptides. Int. J. Biol. Macromol., 2011, 48, 423-431.
29. Endicott, J.A.; Noble, M.E.; Tucker, J.A. Cyclin-dependent kinases: inhibition and substrate recognition. Curr. Opin. Struct. Biol., 1999, 9, 738-744.
30. Ubersax, J.A.; Woodbury, E.L.; Quang, P.N.; Paraz, M.; Blethrow, J.D.; Shah, K.; Shokat, K.M.; Morgan, D.O. Targets of the cyclindependent kinase Cdk1. Nature, 2003, 425, 859-864.
31. Slice, L.W.; Taylor, S.S. Expression of the catalytic subunit of cAMP-dependent protein kinase in Escherichia coli. J. Biol. Chem., 1989, 264, 20940-20946.
32. Zetterqvist, O.Z.; Ragnarsson, U.; Engstrom, L. Substrate specificity of cyclic AMP-dependent protein kinase. In: Peptides and protein phosphorylation; Kemp, B.E., Ed.; CRC Press, Inc: Boca Raton, Florida, 1990; pp. 171-187.
33. Barja, P.; Alavi-Nassab, A.; Turck, CW.; Freire-Moar, J. Inhibition of T-cell activation by protein kinase C pseudosubstrates. Cell Immunol., 1994, 153, 28-38.
34. Bruneau, L.; Chapman, R.; Marsolais, F. Co-occurrence of both Lasparaginase subtypes in Arabidopsis: At3g16150 encodes a K+-dependent L-asparaginase. Planta, 2006, 224, 668-679.
35. Lin, J.S.; Lee, S.K.; Chen, Y.; Lin, W.D.; Kao, C.H. Purification and Characterization of a Novel Extracellular Tripeptidyl Peptidase from Rhizopus oligosporus. J. Agric. Food Chem., 2011, 59, 11330-11337.
36. Shan, L. GKVLAK-(Gadolinium-(1,4,7,10-tetraazacyclododecane-1,4,7-tris(acetic acid t-butyl ester)-10-acetic acid monoamide))-GGGGTVQQEL. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2011.
37. Higgins-Gruber, S.L.; Mutucumarana, V.P.; Lin, P.J.; Jorgenson, J.W.; Stafford, D.W.; Straight, D.L. Effect of vitamin K-dependent protein precursor propeptide, vitamin K hydroquinone, and glutamate substrate binding on the structure and function of {gamma}glutamyl carboxylase. J. Biol. Chem., 2010, 285, 31502-31508.
38. Bukys, M. A.; Orban, T.; Kim, P. Y.; Nesheim, M. E.; Kalafatis, M. The interaction of fragment 1 of prothrombin with the membrane surface is a prerequisite for optimum expression of factor Va cofactor activity within prothrombinase. Thromb. Haemost., 2008, 99, 511-522.
39. Olson, T.S.; Terlecky, S.R.; Dice, J.F. Targeting specific proteins for lysosomal proteolysis. Biomed. Biochim. Acta, 1991, 50, 393-397.
40. Uckun, F.M.; Ek, R.O.; Jan, S.T.; Chen, C.L.; Qazi, S. Targeting SYK kinase-dependent anti-apoptotic resistance pathway in Blineage acute lymphoblastic leukaemia (ALL) cells with a potent SYK inhibitory pentapeptide mimic. Br. J. Haematol., 2010, 149, 508-517.
41. Gouda, H.; Sunazuka, T.; Iguchi, K.; Sugawara, A.; Hirose, T.; Noguchi, Y.; Saito, Y.; Yanai, Y.; Yamamoto, T.; Watanabe, T.; Shiomi, K.; Omura, S.; Hirono, S. Computer-aided rational molecular design of argifin-derivatives with increased inhibitory activity against chitinase B from Serratia marcescens. Bioorg. Med. Chem. Lett., 2009, 19, 2630-2633.
42. Soto, C.; Sigurdsson, E.M.; Morelli, L.; Kumar, R.A.; Castaño, E.M.; Frangione, B. Beta-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: implications for Alzheimer's therapy. Nat. Med., 1998, 4, 822-826.
43. Levine, R. A.; Petokas, S.; Starr, A.; Eich, R. H. Effect of verapamil on basal and pentagastrin-stimulated gastric acid secretion. Clin. Pharmacol. Ther., 1983, 34, 399-402.
44. Takenaka, Y.; Shimano, T.; Mori, T.; Hou, I. C.; Ohinata, K.; Yoshikawa, M. Enterostatin reduces serum cholesterol levels by way of a CCK(1) receptor-dependent mechanism. Peptides, 2008, 29, 2175-2178.
45. Belitsky, M.; Avshalom, H.; Erental, A.; Yelin, I.; Kumar, S.; London, N.; Sperber, M.; Schueler-Furman, O.; Engelberg-Kulka, H. The Escherichia coli extracellular death factor EDF induces the endoribonucleolytic activities of the toxins MazF and ChpBK. Mol. Cell, 2011, 41, 625-635
46. Hayes, F. Moving in for the kill: activation of an endoribonuclease toxin by a quorum-sensing peptide. Mol. Cell, 2011, 41, 617-618.
47. Erental, A.; Sharon, I.; Engelberg-Kulka, H. Two programmed cell death systems in Escherichia coli: an apoptotic-like death is inhibited by the mazEF-mediated death pathway. PLoS Biol., 2012, 10, e1001281.
48. Whitfield, J.F.; Isaacs, R.J.; Chakravarthy, B.R.; Durkin, J.P.; Morley, P.; Neugebauer, W.; Williams, R.E.; Willick, G.; Rixon, R.H. C-terminal fragments of parathyroid hormone-related protein, PTHrP-(107-111) and (107-139), and the N-terminal PTHrP-(1-40) fragment stimulate membrane-associated protein kinase C activity in rat spleen lymphocytes. J. Cell Physiol., 1994, 158, 518-522.
49. Stephenson, S.; Mueller, C.; Jiang, M.; Perego, M. Molecular analysis of Phr peptide processing in Bacillus subtilis. J. Bacteriol., 2003, 185, 4861-4871.
50. Kiyonari, S.; Takayama, K.; Nishida, H.; Ishino, Y. Identification of a novel binding motif in Pyrococcus furiosus DNA ligase for the functional interaction with proliferating cell nuclear antigen. J. Biol. Chem., 2006, 281, 28023-28032.
51. Hattori, N.; Nomoto, H.; Fukumitsu, H.; Mishima, S.; Furukawa, S. Royal jelly-induced neurite outgrowth from rat pheochromocytoma PC12 cells requires integrin signal independent of activation of extracellular signal-regulated kinases. Biomed. Res., 2007, 28, 139-146.
52. Komazawa, H.; Mori, H.; Kojima, M.; Itoh, I.; Murata, J.; Azuma, I.; Saiki, I. Antimetastatic activities of synthetic Arg-Gly-Asp-Ser (RGDS) and Arg-Leu-Asp-Ser (RLDS) peptide analogues and their inhibitory mechanisms. Biol. Pharm. Bull., 1995, 18, 1681-1688.
53. Fujii, H.; Nishikawa, N.; Komazawa, H.; Suzuki, M.; Kojima, M.; Itoh, I.; Obata, A.; Ayukawa, K.; Azuma, I.; Saiki, I. A new pseudo-peptide of Arg-Gly-Asp (RGD) with inhibitory effect on tumor metastasis and enzymatic degradation of extracellular matrix. Clin. Exp. Metastasis, 1998, 16, 94-104.
54. Yoshida, N.; Ishii, E.; Nomizu, M.; Yamada, Y.; Mohri, S.; Kinukawa, N.; Matsuzaki, A.; Oshima, K.; Hara, T.; Miyazaki, S. The laminin-derived peptide YIGSR (Tyr-Ile-Gly-Ser-Arg) inhibits human pre-B leukaemic cell growth and dissemination to organs in SCID mice. Br. J. Cancer, 1999, 80, 1898-1904.
55. Kosfeld, M. D.; Frazier, W. A. Identification of active peptide sequences in the carboxyl-terminal cell binding domain of human thrombospondin-1. J. Biol. Chem., 1992, 267, 16230-16236.
56. Hattori, A.; Hozumi, K.; Ko, JA.; Chikama, T.; Oomikawa, K.; Kato, J.; Ishida, K.; Hoshi, N.; Katagiri, F.; Kikkawa, Y.; Nomizu, M.; Nishida, T. Sequence specificity of the PHSRN peptide from fibronectin on corneal epithelial migration. Biochem. Biophys. Res. Commun., 2009, 379, 346-350.
57. Miyamoto, T.; Tamura, M.; Kabashima, N.; Serino, R.; Shibata, T.; Furuno, Y.; Miyazaki, M.; Baba, R.; Sato, N.; Doi, Y.; Okazaki, M.; Otsuji, Y. An integrin-activating peptide, PHSRN, ameliorates inhibitory effects of conventional peritoneal dialysis fluids on peritoneal wound healing. Nephrol. Dial. Transplant., 2010, 25, 1109-1119.
58. Mazor, Y.; Gilead, S.; Benhar, I.; Gazit, E. Identification and characterization of a novel molecular-recognition and self-assembly domain within the islet amyloid polypeptide. J. Mol. Biol., 2002, 322, 1013-1024.
59. Zhao, T.; Weinhold, P.S.; Lee, NY.; Dahners, L.E. Some observations on the subfibrillar structure of collagen fibrils as noted during treatment with NKISK and cathepsin G with mechanical agitation. J. Electron. Microsc., (Tokyo), 2011, 60, 177-182.
60. Kosfeld, M.D.; Frazier, W.A. Identification of a new cell adhesion motif in two homologous peptides from the COOH-terminal cell binding domain of human thrombospondin. J. Biol. Chem., 1993, 268, 8808-8814.
61. Bogusky, M.J.; Naylor, A.M.; Mertzman, M.E.; Pitzenberger, S.M.; Nutt, R.F.; Brady, S.F.; Colton, C.D.; Veber, D.F. The solution conformation of Ac-Pen-Arg-Gly-Asp-Cys-OH, a potent fibrinogen receptor antagonist. Biopolymers, 1993, 33, 1287-1297.
62. Gartner, T.K.; Loudon, R.; Taylor, D.B. The peptides APLHK, EHIPA and GAPL are hydropathically equivalent peptide mimics of a fibrinogen binding domain of glycoprotein IIb/IIIa. Biochem. Biophys. Res. Commun., 1991, 180, 1446-1452.
63. Zhong, Z.; Davidescu, A.; Ehrén, I.; Ekberg, K.; Jörnvall, H.; Wahren, J.; Chibalin, A.V. C-peptide stimulates ERK1/2 and JNK MAP kinases via activation of protein kinase C in human renal tubular cells. Diabetologia, 2005, 48, 187-197.
64. Clark, R.G.; Thomas, G.B.; Mortensen, D.L.; Won, W.B.; Ma, Y.H.; Tomlinson, E.E.; Fairhall, KM.; Robinson, IC. Growth hormone secretagogues stimulate the hypothalamic-pituitary-adrenal axis and are diabetogenic in the Zucker diabetic fatty rat. Endocrinology, 1997, 138, 4316-4323.
65. Lucchese, G.; Stufano, A.; Trost, B.; Kusalik, A.; Kanduc, D. Peptidology: short amino acid modules in cell biology and immunology. Amino Acids, 2007, 33, 703-707.
66. Kanduc, D. Homology, similarity, and identity in peptide epitope immunodefinition. J. Pept. Sci., 2012, 18, 487-494.
67. Vita, R.; Zarebski, L.; Greenbaum, J.A.; Emami, H.; Hoof, I.; Salimi, N.; Damle, R.; Sette, A.; Peters, B. The immune epitope database 2.0. Nucleic Acids Res., 2010, 38, D854-D862.
68. Liebers, V.; Raulf, M.; Mazur, G.; Modrow, S.; Baur, X. Epitope mapping with peptides of Chi t I component III and immunomodulation of the Chi t immune response. J. Allergy Clin. Immunol., 1993, 92, 334-339.
69. Kaplan, D.; Ferrari, I.; Bergami, P.L.; Mahler, E.; Levitus, G.; Chiale, P.; Hoebeke, J.; Van Regenmortel, M.H.; Levin, M.J. Antibodies to ribosomal P proteins of Trypanosoma cruzi in Chagas disease possess functional autoreactivity with heart tissue and differ from anti-P autoantibodies in lupus. Proc. Natl. Acad. Sci., U.S.A., 1997, 94, 10301-10306.
70. Commandeur, U.; Koenig, R.; Manteuffel, R.; Torrance, L.; Lüddecke, P.; Frank, R. Location, size, and complexity of epitopes on the coat protein of beet necrotic yellow vein virus studied by means of synthetic overlapping peptides. Virology, 1994, 198, 282-287.
71. Agapov, I.I.; Tonevitsky, A.G.; Maluchenko, N.V.; Moisenovich, M.M.; Bulah, Y.S.; Kirpichnikov, M.P. Mistletoe lectin A-chain unfolds during the intracellular transport. FEBS Lett., 1999, 464, 63-66.
72. Agrawal, B.; Longenecker, BM. MUC1 mucin-mediated regulation of human T-cells. Int. Immunol., 2005, 17, 391-399.
73. Liljeqvist, J.A.; Trybala, E.; Hoebeke, J.; Svennerholm, B.; Bergström, T. Monoclonal antibodies and human sera directed to the secreted glycoprotein G of herpes simplex virus type 2 recognize type-specific antigenic determinants. J. Gen. Virol., 2002, 83, 157-165.
74. Gubbins, M.J.; Berry, J.D.; Corbett, C.R.; Mogridge, J.; Yuan, X.Y.; Schmidt, L.; Nicolas, B.; Kabani, A.; Tsang, R.S. Production and characterization of neutralizing monoclonal antibodies that recognize an epitope in domain 2 of Bacillus anthracis protective antigen. FEMS Immunol. Med. Microbiol., 2006, 47, 436-443.
75. Baker, D.A.; Drakeley, C.J.; Ong, C.S.; Lulat, A.G.; Greenwood, B.M.; Targett, G.A. Humoral immune responses in Gambians to Pfs16, an immunodominant Plasmodium falciparum integral membrane protein. Parasite Immunol., 1996, 18, 527-533.
76. Geluk, A.; Van Meijgaarden, K.E.; Janson, A.A.; Drijfhout, J.W.; Meloen, R.H.; De Vries, R.R.; Ottenhoff, T.H. Functional analysis of DR17(DR3)-restricted mycobacterial T-cell epitopes reveals DR17-binding motif and enables the design of allele-specific competitor peptides. J. Immunol., 1992, 149, 2864-2871.
77. Walsh, B.J.; Howden, M.E. A method for the detection of IgE binding sequences of allergens based on a modification of epitope mapping. J. Immunol. Methods, 1989, 121, 275-280.
78. Zhong, G.M.; Brunham, R.C. Antigenic determinants of the chlamydial major outer membrane protein resolved at a single amino acid level. Infect. Immun., 1991, 59, 1141-1147.
79. Batteiger, B.E. The major outer membrane protein of a single Chlamydia trachomatis serovar can possess more than one serovar-specific epitope. Infect. Immun., 1996, 64, 542-547.
80. Borisova, G.; Borschukova, O.; Skrastina, D.; Dislers, A.; Ose, V.; Pumpens, P.; Grens, E. Behavior of a short preS1 epitope on the surface of hepatitis B core particles. Biol. Chem., 1999, 380, 315-324.
81. Takai, T.; Yuuki, T.; Okumura, Y.; Mori, A.; Okudaira, H. Determination of the N-and C-terminal sequences required to bind human IgE of the major house dust mite allergen Der f 2 and epitope mapping for monoclonal antibodies. Mol. Immunol., 1997, 34, 255-261.
82. Ueno, T.; Misawa, S.; Ohba, Y.; Matsumoto, M.; Mizunuma, M.; Kasai, N.; Tsumoto, K.; Kumagai, I.; Hayashi, H. Isolation and characterization of monoclonal antibodies that inhibit hepatitis C virus NS3 protease. J. Virol., 2000, 74, 6300-6308.
83. Fischer, M.J.; Kuipers, C.; Hofkes, R.P.; Hofmeyer, L.J.; Moret, E.E.; de Mol, N.J. Exploring computational lead optimisation with affinity constants obtained by surface plasmon resonance for the interaction of PorA epitope peptides with antibody against Neisseria meningitidis. Biochim. Biophys. Acta, 2001, 1568, 205-215.
84. Michaelsen, T.E.; Ihle, Ø.; Beckstrøm, K.J.; Herstad, T.K.; Kolberg, J.; Høiby, EA.; Aase, A. Construction and functional activities of chimeric mouse-human immunoglobulin G and immunoglobulin M antibodies against the Neisseria meningitidis PorA P1.7 and P1.16 epitopes. Infect. Immun., 2003, 71, 5714-5723.
85. Niikura, M.; Ikegami, T.; Saijo, M.; Kurata, T.; Kurane, I.; Morikawa, S. Analysis of linear B-cell epitopes of the nucleoprotein of ebola virus that distinguish ebola virus subtypes. Clin. Diagn. Lab. Immunol., 2003, 10, 83-87.
86. Williamson, P.; Matthews, R. Epitope mapping the Fim2 and Fim3 proteins of Bordetella pertussis with sera from patients infected with or vaccinated against whooping cough. FEMS Immunol. Med. Microbiol., 1996, 13, 169-178.
87. Matthews, R.; Burnie, J.P.; Lee, W. The application of epitope mapping in the development of a new serological test for systemic candidosis. J. Immunol. Methods, 1991, 143, 73-79.
88. Hashiguchi, S.; Hino, K.; Taniguchi, Y.; Kurimoto, M.; Fukuda, K.; Ohyama, M.; Fujiyoshi, T.; Sonoda, S.; Nishimura, Y.; Yamada, G.; Sugimura, K. Immunodominance of seven regions of a major allergen, Cry j 2, of Japanese cedar pollen for T-cell immunity. Allergy, 1996, 51, 621-632.
89. Moran, E.; Simmons, C.; Vinh Chau, N.; Luhn, K.; Wills, B.; Dung, N.P.; Thao, L.T.T.; Hien, T.T.; Farrar, J.; Rowland-Jones, S.; Dong, T. Preservation of a critical epitope core region is associated with the high degree of flaviviral cross-reactivity exhibited by a dengue-specific CD4+ T-cell clone. Eur. J. Immunol., 2008, 38, 1050-1057.
90. Godkin, A.J.; Thomas, H.C.; Openshaw, P.J. Evolution of epitopespecific memory CD4(+) T-cells after clearance of hepatitis C virus. J. Immunol., 2002, 169, 2210-2214.
91. Ketterlinus, R.; Wiegers, K. Mapping of antigenic domains in poliovirus VP1 nvolved in structural rearrangements during virus morphogenesis and antigenic alterations of the virion. Virology, 1994, 204, 27-37.
92. Wiegers, K.; Uhlig, H.; Dernick, R. N-AgIB of poliovirus type 1: a discontinuous epitope formed by two loops of VP1 comprising residues 96-104 and 141-152. Virology, 1989, 170, 583-6.
93. Ewing, C.; Ebringer, R.; Tribbick, G.; Geysen, H.M. Antibody activity in ankylosing spondylitis sera to two sites on HLA B27.1 at the MHC groove region (within sequence 65-85), and to a Klebsiella pneumoniae nitrogenase reductase peptide (within sequence 181-199). J. Exp. Med., 1990, 171, 1635-1647.
94. Reynolds, C.; Page, G.; Zhou, H.; Chow, M. Identification of residues in VP2 that contribute to poliovirus neutralization antigenic site 3B. Virology, 1991, 184, 391-396.
95. Sesardic, D.; Khan, V.; Corbel, M.J. Targeting of specific domains of diphtheria toxin by site-directed antibodies. J. Gen. Microbiol., 1992, 138, 2197-2203.
96. Ho, H.T.; Qian, H.L.; He, F.; Meng, T.; Szyporta, M.; Prabhu, N.; Prabakaran, M.; Chan, K.P.; Kwang, J. Rapid detection of H5N1 subtype influenza viruses by antigen capture enzyme-linked immunosorbent assay using H5-and N1-specific monoclonal antibodies. Clin. Vaccine Immunol., 2009, 16, 726-732.
97. Reimann, B.Y.; Zell, R.; Kandolf, R. Mapping of a neutralizing antigenic site of Coxsackievirus B4 by construction of an antigen chimera. J. Virol., 1991, 65, 3475-3480.
98. Hakkaart, G.A.; Aalberse, R.C.; van Ree, R. Epitope mapping of the house-dust-mite allergen Der p 2 by means of site-directed mutagenesis. Allergy, 1998, 53, 165-172.
99. Hijnen, M.; Mooi, F.R.; van Gageldonk, P.G.; Hoogerhout, P.; King, A.J.; Berbers, G.A. Epitope structure of the Bordetella pertussis protein P.69 pertactin, a major vaccine component and protective antigen. Infect. Immun., 2004, 72, 3716-3723.
100. Yu, D.T.; Hamachi, T.; Hamachi, M.; Tribbick, G. Analysis of the molecular mimicry between HLA-B27 and a bacterial OmpA protein using synthetic peptides. Clin. Exp. Immunol., 1991, 85, 510-514.
101. Register, R.B.; Uncapher, C.R.; Naylor, A.M.; Lineberger, D.W.; Colonno, R.J. Human-murine chimeras of ICAM-1 identify amino acid residues critical for rhinovirus and antibody binding. J. Virol., 1991, 65, 6589-6596.
102. Schroeter, S.; Khan, K.; Barbour, R.; Doan, M.; Chen, M.; Guido, T.; Gill, D.; Basi, G.; Schenk, D.; Seubert, P.; Games, D. Immunotherapy reduces vascular amyloid-beta in PDAPP mice. J. Neurosci., 2008, 28, 6787-6793.
103. Wang, B.; Hua, R.H.; Tian, Z.J.; Chen, N.S.; Zhao, F.R.; Liu, T.Q.; Wang, Y.F.; Tong, G.Z. Identification of a virus-specific and conserved B-cell epitope on NS1 protein of Japanese encephalitis virus. Virus Res., 2009, 141, 90-95.
104. Garcia-Rodriguez, C.; Levy, R.; Arndt, J.W.; Forsyth, C.M.; Razai, A.; Lou, J.; Geren, I.; Stevens, R.C.; Marks, J.D. Molecular evolution of antibody cross-reactivity for two subtypes of type A botulinum neurotoxin. Nat. Biotechnol., 2007, 25, 107-116.
105. Miyazaki, I.; Cheung, R.K.; Gaedigk, R.; Hui, M.F.; Van der Meulen, J.; Rajotte, R.V.; Dosch, H.M. T-cell activation and anergy to islet cell antigen in type I diabetes. J. Immunol., 1995, 154, 1461-1469.
106. Schulte, S.; Unger, C.; Mo, J.A.; Wendler, O.; Bauer, E.; Frischholz, S.; von der Mark, K.; Kalden, J.R.; Holmdahl, R.; Burkhardt, H. Arthritis-related B-cell epitopes in collagen II are conformationdependent and sterically privileged in accessible sites of cartilage collagen fibrils. J. Biol. Chem., 1998, 273, 1551-1561.
107. Selvey, L.A.; Tindle, R.W.; Geysen, H.M.; Haller, C.J.; Smith, J.A.; Frazer, I.H. Identification of B-epitopes in the human papillomavirus 18 E7 open reading frame protein. J. Immunol., 1990, 145, 3105-3110.
108. Tindle, R.W.; Croft, S.; Herd, K.; Malcolm, K.; Geczy, A.F.; Stewart, T.; Fernando, G.J. A vaccine conjugate of 'ISCAR' immunocarrier and peptide epitopes of the E7 cervical cancer-associated protein of human papillomavirus type 16 elicits specific Th1-and Th2-type responses in immunized mice in the absence of oil-based adjuvants. Clin. Exp. Immunol., 1995, 101, 265-271.
109. Berton, M.T.; Webster, R.G. The antigenic structure of the influenza B virus hemagglutinin: operational and topological mapping with monoclonal antibodies. Virology, 1985, 143, 583-594.
110. Tindle, R.W.; Smith, J.A.; Geysen, H.M.; Selvey, L.A, Frazer, I.H. Identification of B epitopes in human papillomavirus type 16 E7 open reading frame protein. J. Gen. Virol., 1990, 71, 1347-1354.
111. Fernando, G.J.; Stenzel, D.J.; Tindle, R.W.; Merza, M.S.; Morein, B.; Frazer, I.H. Peptide polymerisation facilitates incorporation into ISCOMs and increases antigen-specific IgG2a production. Vaccine, 1995, 13, 1460-1467.
112. Gao, L.; Chain, B.; Sinclair, C.; Crawford, L.; Zhou, J.; Morris, J.; Zhu, X.; Stauss, H. Immune response to human papillomavirus type 16 E6 gene in a live vaccinia vector. J. Gen. Virol., 1994, 75, 157-164.
113. Dillner, L.; Heino, P.; Moreno-Lopez, J.; Dillner, J. Antigenic and immunogenic epitopes shared by human papillomavirus type 16 and bovine, canine, and avian papillomaviruses. J. Virol., 1991, 65, 6862-6871.
114. Mikol, D.D.; Ditlow, C.; Usatin, D.; Biswas, P.; Kalbfleisch, J.; Milner, A.; Calenoff, E. Serum IgE reactive against small myelin protein-derived peptides is increased in multiple sclerosis patients. J. Neuroimmunol., 2006, 180, 40-49.
115. Hemmer, B.; Kondo, T.; Gran, B.; Pinilla, C.; Cortese, I.; Pascal, J.; Tzou, A.; McFarland, H.F.; Houghten, R.; Martin, R. Minimal peptide length requirements for CD4(+) T-cell clones-implications for molecular mimicry and T-cell survival. Int. Immunol., 2000, 12, 375-383.
116. Runkel, L.; De Dios, C.; Karpusas, M.; Baker, D.; Li, Z.; Zafari, M.; Betzenhauser, M.; Muldowney, C.; Miller, S.; Redlich, P.N.; Grossberg, S.E.; Whitty, A.; Hochman, P.S. Mapping of IFN-beta epitopes important for receptor binding and biologic activation: comparison of results achieved using antibody-based methods and alanine substitution mutagenesis. J. Interferon Cytokine Res., 2001, 21, 931-941.
117. Bresson, D.; Pugnière, M.; Roquet, F.; Rebuffat, S.A.; N-Guyen, B.; Cerutti, M.; Guo, J.; McLachlan, S.M.; Rapoport, B.; Estienne, V.; Ruf, J.; Chardès, T.; Péraldi-Roux, S. Directed mutagenesis in region 713-720 of human thyroperoxidase assigns 713KFPED717 residues as being involved in the B domain of the discontinuous immunodominant region recognized by human autoantibodies. J. Biol. Chem., 2004, 279, 39058-39067.
118. Chou, H.; Tam, M.F.; Lee, S.S.; Tang, R.B.; Lin, T.H.; Tai, H.Y.; Chen, Y.S.; Shen, H.D. Asp159 is a critical core amino acid of an IgE-binding and cross-reactive epitope of a dust mite allergen Der f 7. Mol. Immunol., 2011, 48, 2130-2134.
119. Chang, Y.J.; Wu, H.L.; Hsu, Y.C.; Hamaguchi, N.; Shi, G.Y.; Shen, M.C.; Lin, S.W. Discontinuous residues of factor IX constitute a surface for binding the anti-factor IX monoclonal antibody A-5. Thromb. Res., 2003, 111, 293-299.
120. Glesner, J.; Wünschmann, S.; Li, M.; Gustchina, A.; Wlodawer, A.; Himly, M.; Chapman, M.D.; Pomés, A. Mechanisms of allergen-antibody interaction of cockroach allergen Bla g 2 with monoclonal antibodies that inhibit IgE antibody binding. PLoS One, 2011, 6, e22223.
121. Reason, D.; Liberato, J.; Sun, J.; Camacho, J.; Zhou, J. Mechanism of Lethal Toxin Neutralization by a Human Monoclonal Antibody Specific for the PA(20) Region of Bacillus anthracis Protective Antigen. Toxins (Basel), 2011, 3, 979-990.
122. Rothbard, J.B. Peptides and the cellular immune response. Ann. Inst. Pasteur, 1986, 137E, 518-526.
123. Rothbard, J.B.; Taylor, W.R. A sequence pattern common to T cell epitopes. EMBO J., 1988, 7, 93-100.
124. Mathews, J.H.; Allan, J.E.; Roehrig, J.T.; Brubaker, J.R.; Uren, M.F.; Hunt, A.R. T-helper cell and associated antibody response to synthetic peptides of the E glycoprotein of Murray Valley encephalitis virus. J. Virol., 1991, 65, 5141-5148.
125. Schuler, M.M.; Nastke, M.D.; Stevanovic, S. SYFPEITHI: database for searching and T-cell epitope prediction. Methods Mol. Biol., 2007, 409, 75-93.
126. Rothbard, J.B.; Gefter, M.L. Interactions between immunogenic peptides and MHC proteins. Annu. Rev. Immunol., 1991, 9, 527-565.
127. Rothbard, J.B.; Pemberton, R.M.; Bodmer, H.C.; Askonas B.A.; Taylor, W.R. Identification of residues necessary for clonally specific recognition of a cytotoxic T-cell determinant. EMBO J., 1989, 8, 2321-2328.
128. Yang X.; Cai, W.; Xu, Z.; Chen, J.; Li, C.; Liu, S.; Yang, Z.; Pan, Q.; Li, M.; Ma, J.; Gao, G. High efficacy and minimal peptide required for the anti-angiogenic and anti-hepatocarcinoma activities of plasminogen K5. J. Cell. Mol. Med., 2010, 14, 2519-2530.
129. Lucchese, G.; Stufano, A.; Kanduc, D. Proposing low-similarity peptide vaccines against Mycobacterium tuberculosis. J. Biomed. Biotechnol., 2010, 832341.
130. Sant'Angelo, D.B.; Robinson, E.; Janeway, C.A. Jr.; Denzin, L.K. Recognition of core and flanking amino acids of MHC class II-bound peptides by the T-cell receptor. Eur. J. Immunol., 2002, 32, 2510-2520.
131. Reddehase, M.J.; Rothbard, J.B.; Koszinowski, U.H. A pentapeptide as minimal antigenic determinant for MHC class I-restricted T lymphocytes. Nature, 1989, 337, 651-653.
132. Kanduc, D.; Stufano, A.; Lucchese, G.; Kusalik, A. Massive peptide sharing between viral and human proteomes. Peptides, 2008, 29,1755-1766.
133. Trost, B.; Kusalik, A.; Lucchese, G.; Kanduc, D. Bacterial peptides are intensively present throughout the human proteome. Self Nonself, 2010, 1, 71-74.
134. Trost, B.; Lucchese, G.; Stufano, A.; Bickis, M.; Kusalik, A.; Kanduc, D. No human protein is exempt from bacterial motifs, not even one. Self Nonself, 2010, 1, 328-334.
135. Kanduc, D. Penta-and hexapeptide sharing between HPV16 and Homo sapiens proteomes. Int. J. Med. Sci., 2009, 1, 383-387.
136. Kanduc, D. Quantifying the possible cross-reactivity risk of an HPV16 vaccine. J. Exp. Ther. Oncol., 2009, 8, 65-76.
137. Kanduc, D. Potential cross-reactivity between HPV16 L1 protein and sudden death-associated antigens. J. Exp. Ther. Oncol., 2011, 9, 159-165.
138. Lucchese, G. A peptide talk between JC virus and the human host: from silent infection to autoimmunity. Immunopharmacol. Immunotoxicol., 2012, 34, 1067-1074.
139. Lucchese, G.; Stufano, A.; Calabrò, M.; Kanduc, D. Charting the peptide crossreactome between HIV-1 and the human proteome. Front. Biosci., 2011, 3, 1385-1400.
140. Kanduc, D. Describing the hexapeptide identity platform between the influenza A H5N1 and Homo sapiens proteomes. Biologics, 2010, 4, 245-261.
141. Ricco, R.; Kanduc, D. Hepatitis B virus and Homo sapiens proteome-wide analysis: A profusion of viral peptide overlaps in neuron-specific human proteins. Biologics, 2010, 4, 75-81.
142. Lucchese, G. Confronting JC virus and Homo sapiens biological signatures. Front. Biosci., 2013, 18: 716-24.
143. Kanduc, D. The self-nonself issue: a confrontation between proteomes. Self Nonself, 2010, 1, 255-258.
144. Capone, G.; Lucchese, G.; Calabrò, M.; Kanduc, D. West Nile virus diagnosis and vaccination: using unique viral peptide sequences to evoke specific immune responses. Immunopharmacol. Immunotoxicol., 2013, 35, 64-70.
145. Lucchese, G.; Stufano, A.; Kanduc, D. Searching for an effective, safe and universal anti-HIV vaccine: Finding the answer in just one short peptide. Self Nonself, 2011, 2, 49-54.
146. Lucchese, G.; Pesce Delfino, A. Using proteomics to develop an anti-Campylobacter jejuni vaccine. Immunopharmacol. Immunotoxicol., 2012, 34, 385-390.
147. Lucchese, A.; Serpico, R.; Guida, A.; Crincoli, V.; Scully, C.; Kanduc, D. Interkeratin peptide-protein interactions that promote HPV16 E7 gene expression. Int. J. Immunopathol. Pharmacol., 2010, 23, 857-864.
148. Angelini, G., Bonamonte, D., Lucchese, A., Favia, G., Serpico, R., Mittelman, A., Simone, S., Sinha, A.A., Kanduc, D. Preliminary data on Pemphigus vulgaris treatment by a proteomics-defined peptide: a case report. J. Transl. Med., 2006, 4, 43.
149. Kanduc, D.; Lucchese, A.; Mittelman, A. Non-redundant peptidomes from DAPs: towards the vaccine? Autoimmun. Rev., 2007, 6, 290-294.
150. Lucchese, G.; Stufano, A.; Kanduc, D. Proteome-guided search for influenza A B-cell epitopes. FEMS Immunol. Med. Microbiol., 2009, 57, 88-92.
151. Wasan, K.M. The role of lymphatic transport in enhancing oral protein and peptide drug delivery. Drug Dev.Ind. Pharm., 2002, 28, 1047-1058.
152. Lin, J.H. Pharmacokinetics of biotech drugs: peptides, proteins and monoclonal antibodies. Curr. Drug Metab., 2009, 10, 661-691.
153. Katsila, T.; Siskos, A.P.; Tamvakopoulos, C. Peptide and protein drugs: the study of their metabolism and catabolism by mass spectrometry. Mass Spectrom. Rev., 2012, 31, 110-133.
154. Kanduc, D. Epitopic peptides with low similarity to the host proteome: towards biological therapies without side effects. Expert Opin. Biol. Ther., 2009, 9, 45-53.
155. Kanduc, D. Peptide cross-reactivity: the original sin of vaccines. Front. Biosci., 2012, 4, 1393-1401.